Curdlan oligosaccharides having higher immunostimulatory activity than curdlan in mice treated with cyclophosphamide

Carbohydr Polym. 2019 Mar 1:207:131-142. doi: 10.1016/j.carbpol.2018.10.120. Epub 2018 Nov 22.

Abstract

This study evaluated the immunostimulatory activity of curdlan oligosaccharides (GOS) in cyclophosphamide (CTX)-induced immunosuppressed mice and in RAW264.7 cells. GOS was able to stimulate the release of nitric oxide (NO), cytokines (IL-1β, IL-6 and TNF-α) and improve the phagocytic rate of peritoneal macrophages and RAW264.7 cells. It further enhanced immunoglobulins (Ig) release (IgG by 50.6%-74.7%, IgA by 31.3%-34.9%, IgM by 28.3%-66.7%), splenic lymphocyte proliferation (by 74.8%-91.3%), nature killer cells cytotoxicity (by 32.0%-49.6%), immunophenotypes of splenic lymphocytes (from 1.7 to 2.4, 2.2 and 2.7) in immunosuppressed mice. Compared with curdlan, higher immunostimulatory activity of GOS was found in CTX-treated mice. Moreover, GOS could activate nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways through toll-like receptor 2 (TLR2) and complement receptor 3 (CR3). These results indicated that GOS may be a favorable candidate of functional food in regulating immune responses.

Keywords: Complement receptor 3; Curdlan oligosaccharides; Immunostimulatory activity; Immunosuppression; Toll-like receptoer 2.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use*
  • Administration, Oral
  • Alcaligenes / chemistry
  • Animals
  • Body Weight / drug effects
  • Cyclophosphamide
  • Cytokines / metabolism
  • Immune System Diseases / drug therapy*
  • Immunity, Humoral / drug effects
  • Immunosuppression Therapy
  • Killer Cells, Natural / metabolism
  • MAP Kinase Signaling System / drug effects
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Oligosaccharides / administration & dosage
  • Oligosaccharides / pharmacology
  • Oligosaccharides / therapeutic use*
  • RAW 264.7 Cells
  • T-Lymphocytes / metabolism
  • beta-Glucans / administration & dosage
  • beta-Glucans / pharmacology
  • beta-Glucans / therapeutic use*

Substances

  • Adjuvants, Immunologic
  • Cytokines
  • Oligosaccharides
  • beta-Glucans
  • curdlan
  • Cyclophosphamide